We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bruker Corporation | NASDAQ:BRKR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.84 | 4.48% | 66.25 | 64.96 | 67.54 | 66.52 | 63.0101 | 63.89 | 695,554 | 22:07:11 |
Bruker Daltonics today launches its next-generation ultrafleXtreme™ MALDI-TOF/TOF mass spectrometer, the only instrument combining true 1 kHz speed in both TOF and TOF/TOF modes with ultra-high performance and extreme flexibility for a broad variety of complementary research, clinical and applied proteomics applications. In proteomics, MALDI-TOF/TOF is highly complementary to ESI-MS/MS with Bruker’s latest high-capacity ion traps with ETD, and to ultra-high resolution (UHR) ESI-Q-q-TOF maXis™ systems, as both MALDI and ESI are required for highest coverage and flexibility in modern protein analysis.
The new ultrafleXtreme incorporates key inventions, Bruker’s proprietary smartbeam-II™ laser technology at 1 kHz, and the latest ion optics innovations. It is the only MALDI-TOF/TOF instrument that truly enables high-throughput 1 kHz biomarker discovery and quantitation, as well as fast, high-performance tissue molecular imaging with a laser spot size close to single cell spatial resolution. LC-MALDI can be performed with unmatched mass resolution, mass accuracy and data acquisition speed. Bruker’s unique Edmass™ protein sequencing capabilities allow very rapid and sensitive intact protein characterization and sequencing with read lengths up to and beyond 80 residues, and with direct analysis of N- and C- terminal modifications.
Industry-leading TOF/TOF technology is incorporated into the ultrafleXtreme for unprecedented capabilities:
Efficient data retrieval and interpretation is provided by fully integrated software platforms designed, progressed and supported by Bruker with leading proteomics experts, for:
Bruker Daltonics Executive Vice President Dr. Ian Sanders commented: “Its incredible flexibility and unparalleled performance make the truly innovative ultrafleXtreme the definitive MALDI-TOF/TOF today. Researchers are enabled for new achievements in proteomics and MALDI imaging, while achieving result quality across the board that would have been undreamed of even a short time ago.”
The capabilities of the new ultrafleXtreme™ will be highlighted at Bruker's Annual Users Meeting on Sunday, May 31st, 2009 before the 57th ASMS Conference on Mass Spectrometry in Philadelphia, PA. For more information on this event, please visit www.bdal.com/asms2009. For further product information please visit www.bdal.com/ultrafleXtreme.
ultrafleXtreme, ProteinScape, PAN, smartbeam, FlashDetector, MALDI Perpetual, BioTools, ProteinScape, FlexImaging are trademarks of Bruker Daltonik GmbH. ICPL is a trademark of TopLab GmbH, and iTRAQ is a trademark of Applied Biosystems.
About Bruker Daltonics: For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit www.bdal.com and www.bruker.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5949225&lang=en
1 Year Bruker Chart |
1 Month Bruker Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions